Association between SLCO1B1, apolipoprotein E and ABCG2 genes and lipid response to rosuvastatin: a meta-analysis
The lipid-lowering efficacy of rosuvastatin (especially the reduction of LDL-C level) is significantly affected by the polymorphisms of SLCO1B1 (c.388A>G), ApoE (c.388T>C, c.526C>T) and ABCG2 (c.421C>A) genes.
Authors
- Deng Yu (ORCID: https://orcid.org/0000-0002-6983-8974)
- Huiyou Li
- Jianhai Li
- Yong Lai
- Limei Yu
- Zhaohen Yin
- Lingyan Liu
- Lei Li
Institutions
- Yunnan Agricultural University (CN)
- 181st Hospital of Chinese People's Liberation Army (CN)
- Dali University (CN)
Publication Details
- Journal
- Pharmacogenetics and Genomics
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1097/fpc.0000000000000592
- Primary Topic
- Cholesterol and Lipid Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00